Precursor Epithelial Subtypes of Adenocarcinoma Arising from Intraductal Papillary Mucinous Neoplasms (A-IPMN): Clinicopathological Features, Recurrence and Response to Adjuvant Chemotherapy.
James LucocqBeate HaugkDaniel ParkinsonAntony DarneNejo JosephJake HawkyardSteve WhiteOmar MownahKrishna MenonTakaki FurukawaYosuke InoueYuki HiroseNaoki SasahiraAnubhav MittalJas SamraAmy SheenMichael FeretisAnita BalakrishnanCarlo CeresaBrian DavidsonRupaly PandeBobby V M DasariLulu TannoDimitrios KaraviasJack HelliwellAlistair YoungQuentin NunesTomas UrbonasMichael SilvaAlex Gordon-WeeksJenifer BarrieDhanny GomezStijn van LaarhovenHossam NawaraJoseph DoyleRicky BhogalEwen HarrisonMarcus RoalsoDeborah CipraniSomaiah ArooriBathiya RatnayakeJonathan KoeaGabriele CapursoRuben BellottiStefan StättnerTareq AlsaoudiNeil BhardwajFraser JefferySaxon ConnorAndrew CameronNigel JamiesonKeith RobertsKjetil SoreideAnthony J GillSanjay PandanaboyanaPublished in: Annals of surgical oncology (2024)
Gastric, pancreatobiliary and mixed subtypes have comparable recurrence and survival outcomes, which are inferior to the more indolent intestinal subtype. Pancreatobiliary subtype may respond to adjuvant chemotherapy and further research is warranted to determine the most appropriate adjuvant chemotherapy regimens for each subtype.